Wahl RL, Ahuja S, Clarke B. Current Landscape of Radiopharmaceutical Therapies: SNMMI Therapy Task Force Survey. J Nucl Med. 2021;62(5):11N-16N.

PubMed  Google Scholar 

Mattsson S, Johansson L, Leide Svegborn S, et al., ICRP. Radiation dose to patients from radiopharmaceuticals. A compendium of current information related to frequently used substances. ICRP publication 128. Ann. ICRP 2015:44(2S).

Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538–46.

PubMed  Google Scholar 

Stabin M, Wendt RE, Flux GD. RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2-Data Analysis and Dosimetry. J Nucl Med. 2022;63(3):485–92.

Article  PubMed  PubMed Central  Google Scholar 

Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry-standardization of nomenclature. J Nucl Medicine. 2009;50(3):477–84.

Article  Google Scholar 

Quantitative nuclear medicine imaging: concepts, requirements and methods. Vienna: International Atomic Energy Agency, 2014. IAEA human health series, ISSN 2074–7667; no. 9.

Lassmann M, Chiesa C, Flux G, Bardiès M. EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging. 2010. https://doi.org/10.1007/s00259-010-1549-3.

Article  PubMed  Google Scholar 

Snyder W, Ford M, Warner G, Fisher H Jr: MIRD Pamphlet no 5—estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom J. Nucl. Med. 1969 (Suppl 3) 5.

Dunford CL, Burrows TW. Online nuclear data service. Upton, NY: Brookhaven National Laboratory. 1999:NNDC/ONL 99/3,IAEA NDS-150,Rev 99/3.

Cristy M, Eckerman K. Specific absorbed fractions of energy at various ages from internal photons sources ORNL/TM-8381 V1-V7 (Oak Ridge, TN: Oak Ridge National Laboratory), 1987. https://www.osti.gov/servlets/purl/6233638.

Stabin M. A model of the prostate gland for use in internal dosimetry. J Nucl Med. 1994;35:516–20.

PubMed  Google Scholar 

Eckerman K, Stabin M. Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions. Health Phys. 2000;78:199–214.

Article  PubMed  Google Scholar 

Holman B, Zimmerman R, Shapiro J, Kaplan M, Jones A, Hill T. Biodistribution and dosimetry of n-isoproyl p-123I iodoamphetamine in the primate. J Nucl Med. 1983;24:922–31.

PubMed  Google Scholar 

Mardirossian G, Tagesson M, Blanco P, Bouchet LG, Stabin M, Yoriyaz H, Baza S, Ljungberg M, Strand S, Brill A. A new rectal model for dosimetry applications. J Nucl Med. 1999;40:1524–31.

PubMed  Google Scholar 

Stabin M, Konijnenberg M. Re–evaluation of absorbed fractions for photons and electrons in small spheres. J Nucl Med. 2000;41:149–60.

PubMed  Google Scholar 

Stabin MG, da Luz CQPL. New decay data for internal and external dose assessment. Health Phys. 2002;83:471–5.

Article  PubMed  Google Scholar 

Mirzaei S, Sohlberg A, Knoll P, et al. Easy-to-use online software package for internal dose assessment after radionuclide treatment in clinical routine. Clin Nucl Med. 2013;38(9):686–90.

Article  PubMed  Google Scholar 

Visser E, Postema E, Boerman O, et al. Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND). Eur J Nucl Med Mol Imaging. 2007;34:413–21.

Article  PubMed  Google Scholar 

Marie-Paule G, Daphnée V, Erin M, et al. TestDose: A nuclear medicine software based on Monte Carlo modeling for generating gamma camera acquisitions and dosimetry. Med Phys. 2015;42:6885–94.

Article  Google Scholar 

Van Wyk B, Hasford F, Nyakale N, Vangu M. An image-based notion for therapeutic planar organ activity dosimetry in a developing country: Masterdose software. Hell J Nucl Med. 2022;25(1):71–82.

PubMed  Google Scholar 

Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine. J Nucl Med. 2005;46:1023–7.

PubMed  Google Scholar 

Mora-Ramirez E, Santoro L, Cassol E, Ocampo-Ramos JC, Clayton N, Kayal G, et al. Comparison of commercial dosimetric software platforms in patients treated with 177Lu-DOTATATE for peptide receptor radionuclide therapy. Med Phys. 2020;47(9):4602–15.

Article  PubMed  Google Scholar 

GE Healthcare. Organ dose estimates for radio-isotope therapy treatment planning purposes. Dosimetry toolkit package. White paper. 2011.

Zubrod C, et al. Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and thiophosphoramide. J Chronic Dis. 1960;11:7–33.

Article  Google Scholar 

Grimes J. Patient-specific internal dose calculation techniques for clinical use in targeted radionuclide therapy. University of British Columbia; 2013. https://open.library.ubc.ca/soa/cIRcle/collections/ubctheses/24/items/1.0073590.

Mora-Ramirez E, Santoro L, Trauchessec D, Chouaf S. Dosimetric estimations using commercial workstations for peptide receptor radionuclide therapy (PRRT) patients treated with 177Lu-DOTATATE. Eur J Nucl Med Mol Imaging. 2017;44S810.

Simulation, analysis, and modeling software. https://tegvirginia.com/software/saam-ii/.  Accessed 19/03/2021.

International Commission on Radiation Units and Measurements. Report 44: Tissue Substitutes in Radiation Dosimetry and Measurement. Bethesda, MD: ICRU; 1989.

Sjogreen Gleisner K, Chouin N, Gabina P, Cicone F, Gnesin S, Stokke C, Konijnenberg M, Cremonesi M, Verburg F, Bernhardt P, Eberlein U, Gear J. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor-and PSMA-targeting ligands. Eur J Nucl Med Mol Imaging. 2002;49:1778–809.

Article  Google Scholar 

Eckerman E, Endo A. ICRP Publication 107: Nuclear decay data for dosimetric calculations. Ann ICRP. 2008;38(3).